Paramount Peptides
PT-141
Finnrick tested 3 samples of PT-141 (Bremelanotide) from Paramount Peptides between 25 Apr 2025 and 7 May 2025. Test scores average over 5, no score below 4, and at least 2 tests warrant a tentative Finnrick Rating of C (Okay).
Finnrick Rating™
Tentative Rating
Paramount Peptides
PT-141
Tested 3 Samples
Last test 7 May 2025
Take Action
Researcher
Request Full Data Access to the Finnrick database of peptide tests.
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other PT-141 tests from top-rated vendors:
All PT-141 tests from Paramount Peptides
Samples are tested in commercial labs
Tests Count
3
Scores
AVGMINMAX
Last
7 May 2025
First
25 Apr 2025
| Quantity | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 7 May 2025 | View | 10mg | 10.660mg | +6.6% | 99.90% | PT-141-0003 | Black Label / Silver Crimp / Clear Yellow Cap | Lab A | Finnrick | |
| 7 May 2025 | View | 10mg | 10.550mg | +5.5% | 99.89% | PT-141-0003 | Black Label / Silver Crimp / Clear Yellow Cap | Lab A | Finnrick | |
| 25 Apr 2025 | View | 10mg | 13.296mg | +33.0% | 98.85% | PT-141-0003 | Black Label / Silver Crimp / Clear Yellow Cap | Lab F | Finnrick | |